Role of Probiotics in SARS-CoV-2 Infection: Review of Evidence
Interspecies transmission of viruses between animals and humans could lead to infections of severe pathogenic potential and cause transmissible diseases of unpredictable clinical outcomes. This situation has been well exemplified by the discovery of new pathogenic viruses, such as the novel severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), which continues to have a massive global impact in terms of economic disruption, and, above all, human health.
While the development of the vaccine is still some time away, and new antiviral agents require a considerable length of time and effort for drug design and validation. While our endeavour to repurpose existing agents continue, it may be borne in mind to consider the regulatory role of probiotics on gut-lung axis, as we briefly review the prophylactic and supportive role of probiotics for the management of COVID-19 as immune response modifying agents (1)